Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Pirker

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
Journal of Neural Transmission (Vienna, Austria : 1996)|February 3, 1999
[123I]beta-CIT and SPECT in essential tremor and Parkinson's diseaseS Asenbaum, W Pirker, P Angelberger, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|March 19, 1999
In vivo visualization of serotonin transporters in the human brain during fluoxetine treatmentJ Tauscher, W Pirker, M de Zwaan, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 16, 1998
Imaging the pre- and postsynaptic side of striatal dopaminergic synapses in idiopathic cervical dystonia: a SPECT study using [123I] epidepride and [123I] beta-CITM Naumann, W Pirker, K Reiners, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 5, 2000
[123I]beta-CIT SPECT in multiple system atrophy, progressive supranuclear palsy, and corticobasal degenerationW Pirker, S Asenbaum, G Bencsits, et al.
Experimental Neurology|April 21, 2001
Coadministration of (-)-OSU6162 with l-DOPA normalizes preproenkephalin mRNA expression in the sensorimotor striatum of primates with unilateral 6-OHDA lesionsW Pirker, J Tedroff, H Pontén, et al.
European Journal of Neurology|June 10, 2014
Subjective memory complaints, depressive symptoms and cognition in Parkinson's disease patientsJ Lehrner, D Moser, S Klug, et al.
Biological Psychiatry|February 9, 2000
Seasonal variation of availability of serotonin transporter binding sites in healthy female subjects as measured by [123I]-2 beta-carbomethoxy-3 beta-(4-iodophenyl)tropane and single photon emission computed tomographyA Neumeister, W Pirker, M Willeit, et al.
Journal of Neural Transmission. Supplementum|January 1, 1997
Measurement of the dopaminergic degeneration in Parkinson's disease with [123I] beta-CIT and SPECT. Correlation with clinical findings and comparison with multiple system atrophy and progressive supranuclear palsyT Brücke, S Asenbaum, W Pirker, et al.
Journal of Neural Transmission. General Section|January 1, 1994
Iodine-123-IBZM-SPECT: studies in 15 patients with pituitary tumorsW Pirker, T Brücke, M Riedl, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 28, 1997
Iodine-123-epidepride-SPECT: studies in Parkinson's disease, multiple system atrophy and Huntington's diseaseW Pirker, S Asenbaum, S Wenger, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Journal of Neural Transmission (Vienna, Austria : 1996)|February 3, 1999
[123I]beta-CIT and SPECT in essential tremor and Parkinson's diseaseS Asenbaum, W Pirker, P Angelberger, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|March 19, 1999
In vivo visualization of serotonin transporters in the human brain during fluoxetine treatmentJ Tauscher, W Pirker, M de Zwaan, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 16, 1998
Imaging the pre- and postsynaptic side of striatal dopaminergic synapses in idiopathic cervical dystonia: a SPECT study using [123I] epidepride and [123I] beta-CITM Naumann, W Pirker, K Reiners, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 5, 2000
[123I]beta-CIT SPECT in multiple system atrophy, progressive supranuclear palsy, and corticobasal degenerationW Pirker, S Asenbaum, G Bencsits, et al.
Experimental Neurology|April 21, 2001
Coadministration of (-)-OSU6162 with l-DOPA normalizes preproenkephalin mRNA expression in the sensorimotor striatum of primates with unilateral 6-OHDA lesionsW Pirker, J Tedroff, H Pontén, et al.
European Journal of Neurology|June 10, 2014
Subjective memory complaints, depressive symptoms and cognition in Parkinson's disease patientsJ Lehrner, D Moser, S Klug, et al.
Biological Psychiatry|February 9, 2000
Seasonal variation of availability of serotonin transporter binding sites in healthy female subjects as measured by [123I]-2 beta-carbomethoxy-3 beta-(4-iodophenyl)tropane and single photon emission computed tomographyA Neumeister, W Pirker, M Willeit, et al.
Journal of Neural Transmission. Supplementum|January 1, 1997
Measurement of the dopaminergic degeneration in Parkinson's disease with [123I] beta-CIT and SPECT. Correlation with clinical findings and comparison with multiple system atrophy and progressive supranuclear palsyT Brücke, S Asenbaum, W Pirker, et al.
Journal of Neural Transmission. General Section|January 1, 1994
Iodine-123-IBZM-SPECT: studies in 15 patients with pituitary tumorsW Pirker, T Brücke, M Riedl, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 28, 1997
Iodine-123-epidepride-SPECT: studies in Parkinson's disease, multiple system atrophy and Huntington's diseaseW Pirker, S Asenbaum, S Wenger, et al.
Pageof 4